U.S. Court in Connecticut Refuses to Certify Action Alleging Cigna Inflated Drug Costs
- May 21, 2021
The U.S. District Court for the District of Connecticut refused May 20 to certify a putative class action alleging Cigna Health and Life Insurance Company and pharmacy benefit manager OptumRx, Inc. schemed to artificially inflate prescription drug costs in violation of health plan terms.
ARTICLE TAGS
You must be logged in to access this content.